These findings demonstrate a direct correlation between meR316-ALKBH5 and the clinical aggressiveness of CRC and reaffirm the function of meR316-ALKBH5 in the clinical outcome of CRC. The gene discussed is ALKBH5; the disease is colorectal carcinoma.